Psychedelic compounds show promise as treatments for several neuropsychiatric conditions such as depression, cluster headaches, migraines, anxiety, and obsessive-compulsive disorder. Historically, basic science has used these compounds to study neurotransmitter systems, primarily the serotonin 5-HT2A receptor. This review covers recent advances in understanding the biological mechanisms of psychedelics, new drug discovery efforts, and potential pitfalls in their widespread therapeutic use. Understanding the pharmacology behind their therapeutic mechanisms is crucial for their safe and effective application.
Psychedelics show promise as treatments for neuropsychiatric disorders, though their clinical potential is not fully understood. This review explores current knowledge of their basic biology, pharmacology, and structural biology, highlighting both established facts and unanswered questions as these compounds gain popularity in therapeutic and recreational settings.